Glucose Empowerment Through Monitoring and Social Support in Pregnancy

This study is looking at whether using a continuous glucose monitor (CGM), which shows your blood sugar levels in real-time on a smartphone app, combined with a group chat for social support, can help pregnant individuals keep their blood sugar at a healthy level. High blood sugar during pregnancy can cause health problems for both you and your baby. Researchers believe that knowing your blood sugar levels instantly might help you make choices, like exercising or drinking water, to lower them. This study aims to enroll 70 pregnant women, aged 18-45, who are less than 20 weeks pregnant, have a BMI over 25, a personal history of gestational diabetes (GDM), or a first-degree family member with type 2 diabetes. You must also own a smartphone, be comfortable in English, and receive prenatal care at Tufts Medicine (Boston). The main goal is to see how this approach affects your confidence in managing your blood sugar.

Study design
This is an interventional study with a planned enrollment of 70 participants. It is not specified if it is randomized or blinded.
What's involved
You would use a continuous glucose monitor and participate in a mobile-based group chat. Your self-efficacy for glucose management will be measured at baseline, and on days 3, 7, 14, and 60 of the study.
Compensation
Not stated in the trial record.
Follow-up
Your self-efficacy for glucose management will be measured up to Day 60 of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07009704

Glucose Empowerment Through Monitoring and Social Support in Pregnancy

Recruiting
NAAges 18–45InterventionalPrevention
Tufts Medical Center
~70 participants
Updated 2025-09-22 on ClinicalTrials.gov
What's tested:Mobile-based social supportReal-time continuous glucose monitoring

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Self-efficacy for glucose management
Measured over Baseline, Day 3 of CGM, Day 7 of CGM, Day 14 of CGM, Day 60 of study
Pregnancy, Complications
Gestational Diabetes
1 sites across 1 states
Massachusetts1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Pregnant (\<20w0d)
At least 18 years to 45 years old
BMI \>25, personal history of GDM, or first-degree family member with type II diabetes
Comfortable conversing in English
Own a smartphone and willing to use the CGM app and Signal
Receiving prenatal care and planning to deliver at Tufts Medicine (Boston)
Signed the consent form
Currently located in the United States

Exclusion

Current pregnancy a multiple gestation (e.g., twins)
Smoked during this current pregnancy
Active hepatitis or HIV infection
Current pregnancy have any documented fetal congenital anomalies
Current history of heroin, cocaine, crack, LSD, or methamphetamines
Current history of alcohol abuse
Previous gastric bypass
Shift work that alters the sleep/wake periods
Have known rheumatological or chronic inflammatory state (i.e., arthritis, inflammatory bowel disease)?
Chronic illnesses, including diabetes and dialysis, that require regular medication use
Uncontrolled hypothyroidism
Known culture of positive chorioamnionitis?
An adult who is unable to consent (e.g., cognitively impaired adults)
Ward of the state
Unable to read or write English
  • Self-efficacy for glucose managementBaseline, Day 3 of CGM, Day 7 of CGM, Day 14 of CGM, Day 60 of study

    Self-efficacy will be adapted from a validated survey of self-efficacy for type II diabetes management (DMSES UK)